Welcome to our dedicated page for MDB Capital Holdings LLC-A news (Ticker: MDBH), a resource for investors and traders seeking the latest updates and insights on MDB Capital Holdings LLC-A stock.
MDB Capital Holdings, LLC reports developments as a public venture platform and investment holding company focused on launching and supporting disruptive technology companies. Its news commonly covers shareholder updates, operating results, portfolio-company positions, capital-market services and the activity of subsidiaries that combine broker-dealer, intellectual property and technology-development functions.
Company updates also feature PatentVest, MDB’s intellectual property intelligence, strategy and legal-services business. Recurring PatentVest releases discuss IP landscape reports, patent strategy, legal insights, biotechnology and medical-technology collaborations, and equity-linked service engagements that connect patent research, due diligence and venture formation.
PatentVest has released its groundbreaking Quantum Computing Pulse Report, analyzing leadership in the emerging $850B quantum computing market. The comprehensive study evaluated 38 companies across various metrics and analyzed 14,762 patent families from 1,743 assignees.
The report reveals three distinct leaders in the startup space: D-Wave Quantum (1,338 publications), Origin Quantum (1,326 publications), and IonQ Inc. (1,224 publications). In the corporate landscape, IBM leads with 1,860 publications, followed by Alphabet (1,223) and Origin Quantum (1,040).
The analysis indicates that quantum computing is transitioning from R&D to commercialization, with success depending on both defensible intellectual property and commercialization capabilities.
MDB Capital Holdings (NASDAQ: MDBH), a public venture platform specializing in disruptive technology companies, has scheduled a Q2 2025 business update conference call for August 27, 2025, at 4:30 p.m. ET. The call will be hosted via Zoom webinar.
CEO and Co-Founder Christopher Marlett will lead the presentation, potentially joined by other management team members. The discussion will cover recent developments, ongoing initiatives, and upcoming milestones, followed by a Q&A session. A press release with detailed Q2 2025 results will be issued before the call.
PatentVest has released a comprehensive report titled "The Next Era of Surgical Robotics" analyzing the $188B surgical robotics market. The report, based on analysis of 18,000+ patent families and $4B in M&A activity, reveals that despite 310 million annual global surgeries, only 6% involve robots.
The study examines 28 robotic platforms and identifies key market players, including Intuitive Surgical as the dominant patent holder, legacy incumbents like Medtronic and Johnson & Johnson, and emerging challengers such as Vicarious Surgical and CMR Surgical. The report highlights how venture-backed platforms are positioning themselves for strategic scale, following the path of successful acquisitions like MAKO, Auris, and Mazor.
ClearSign Technologies Corporation (CLIR) announced significant changes to its Board of Directors. The Board expanded from five to seven directors with the appointment of Anthony DiGiandomenico and Lou Basenese, effective May 22, 2025. Additionally, David M. Maley will not seek re-election at the 2025 annual stockholders meeting.
DiGiandomenico, co-founder and Chief of Transactions at MDB Capital Holdings, brings extensive experience in early-stage disruptive technologies. Basenese, currently Executive VP of Market Strategy at Prairie Operating Co. and CEO of The Basenese Group, contributes over 25 years of experience in equity research, investment banking, and strategic planning.
MDB Capital Holdings (NASDAQ: MDBH), a public venture platform specializing in launching disruptive technology companies, has released its Q1 2025 operational update. Key highlights include: successfully closing an $11.5 million public offering for HeartBeam (NASDAQ: BEAT), securing LOIs for 3 new "Big Idea" companies, and growing their MDB Direct accounts by 26% with 111 new additions. The company reported a 4.5% increase in its shareholder base during Q1 2025.
The company is expanding its relationships with angel groups, RIAs, and family offices while exploring new ways to leverage its self-clearing platform. MDB has also implemented a revised executive compensation plan for four top executives to better align with shareholder interests. CEO Christopher Marlett noted continued interest from micro-cap companies seeking to go public despite market volatility.
MDB Capital Holdings (NASDAQ: MDBH), a public venture platform specializing in launching disruptive technology companies, has announced its upcoming first quarter 2025 earnings conference call. The Zoom webinar is scheduled for Wednesday, May 21, 2025, at 4:30 p.m. Eastern Time.
CEO and Co-Founder Christopher Marlett will lead the presentation, accompanied by other management team members. The discussion will cover Q1 2025 results, recent developments, ongoing initiatives, and future milestones. The company will release its detailed financial results before the call. Investors can access the webinar through pre-registration or MDB's investor relations website.
PatentVest has released a comprehensive report on the brain-computer interface (BCI) market, projected to exceed $400 billion in the US. The report analyzes over 2,160 patent families across 664 entities in the neurotechnology sector.
The market comprises $80 billion in high-acuity, early-adopting patient populations and $320 billion in potential long-term applications for neurological and psychiatric conditions. While Neuralink maintains high visibility, Synchron is establishing category leadership through minimally invasive platforms and targeted IP strategy across 10 jurisdictions.
The report highlights key players including INBRAIN, Blackrock, Precision Neuroscience, and Paradromics, who are securing market positions through differentiated technologies and IP consolidation. Academic institutions like Tianjin University, Stanford, and the University of California continue to hold foundational patents in neural signal processing and interface architecture.
MDB Capital Holdings (NASDAQ: MDBH) has released its Q4 and full-year 2024 update, highlighting significant operational achievements in the public venture platform space. Key accomplishments include:
- Successfully launched eXoZymes Inc (EXOZ) through IPO, maintaining ~47% ownership
- Expanded analyst team to 14 members, screening 8,964 companies and deeply examining 217 potential market leaders
- Grew shareholder base by 12% with 456 new brokerage accounts
- Increased assets under management from $2M to $44M
- Launched first self-clearing broker-dealer platform for public venture investing
- Expanded PatentVest client base from 3 to 8 clients
The company filed its Form 10-K on March 31, including consolidated financial results through November 14, 2024, when eXoZymes was deconsolidated following its IPO.